Literature DB >> 17599603

Effect of cardiac and noncardiac conditions on survival after defibrillator implantation.

Douglas S Lee1, Jack V Tu, Peter C Austin, Paul Dorian, Raymond Yee, Alice Chong, David A Alter, Andreas Laupacis.   

Abstract

OBJECTIVES: We sought to examine outcomes in recipients of implantable cardioverter-defibrillators (ICDs) and the effect of age, gender, and comorbidities on survival.
BACKGROUND: Age, gender, and comorbidities may significantly affect outcomes in ICD recipients.
METHODS: We examined factors associated with mortality in 2,467 ICD recipients in Ontario, Canada, using a province-wide database. Comorbidities were identified retrospectively by examining all diagnosis codes within the 3 years before implant.
RESULTS: Mean ages at ICD implant were 63.2 +/- 12.5 years (1,944 men) and 59.8 +/- 15.9 years (523 women). Mortality rates at one and 2 years were 7.8% and 14.0%. Older age at implant increased the risk of death with hazard ratios (HR) of 2.05 (95% confidence interval [CI] 1.70 to 2.47) and 3.00 (95% CI 2.43 to 3.71) for those 65 to 74 years and >/=75 years, respectively (both p < 0.001), but gender was not a predictor of death. Common noncardiac conditions associated with death included peripheral vascular disease (adjusted HR 1.50, 95% CI 1.18 to 1.91), pulmonary disease (adjusted HR 1.35, 95% CI 1.10 to 1.66), and renal disease (adjusted HR 1.57, 95% CI 1.25 to 1.99). Many ICD recipients had prior heart failure (46.2%) with an increased HR of 2.33 for death (95% CI 1.96 to 2.76; p < 0.001). Greater comorbidity burden conferred increased risk, with HRs adjusted for age, gender, and heart failure of 1.72 (95% CI 1.44 to 2.05), 2.79 (95% CI 2.15 to 3.62), and 2.98 (95% CI 1.74 to 5.10) for those with 1, 2, and 3 or more noncardiac comorbidities, respectively (all p < 0.001).
CONCLUSIONS: Age, noncardiac comorbidities, and prior heart failure influence survival outcomes in ICD recipients. These factors should be considered in the care of ICD recipients.

Entities:  

Mesh:

Year:  2007        PMID: 17599603     DOI: 10.1016/j.jacc.2007.02.058

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  37 in total

1.  Patients' perspectives on end-of-life issues and implantable cardioverter defibrillators.

Authors:  Patricia H Strachan; Sandra L Carroll; Sonya de Laat; Lisa Schwartz; Heather M Arthur
Journal:  J Palliat Care       Date:  2011       Impact factor: 2.250

2.  Geriatric Conditions in Patients Undergoing Defibrillator Implantation for Prevention of Sudden Cardiac Death: Prevalence and Impact on Mortality.

Authors:  Ariel R Green; Bruce Leff; Yongfei Wang; Erica S Spatz; Frederick A Masoudi; Pamela N Peterson; Stacie L Daugherty; Daniel D Matlock
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-12-29

3.  Outcomes in heart failure patients referred for consideration of implantable cardioverter defibrillator for primary prophylaxis of sudden cardiac death: what are the risks of waiting?

Authors:  Nina Ghosh; Iqwal Mangat; Suzan S O'Donnell; Arnold Pinter; Victoria Korley; Chris Lane; Paul Dorian
Journal:  Can J Cardiol       Date:  2009-10       Impact factor: 5.223

4.  Subject of the year: who are we missing, who are we overtreating, and who is best served? Refining the prescription of implantable cardioverter-defibrillator therapy.

Authors:  Andrew E Epstein
Journal:  J Interv Card Electrophysiol       Date:  2009-11       Impact factor: 1.900

5.  Using physician billing claims from the Ontario Health Insurance Plan to determine individual influenza vaccination status: an updated validation study.

Authors:  Kevin L Schwartz; Nathaniel Jembere; Michael A Campitelli; Sarah A Buchan; Hannah Chung; Jeffrey C Kwong
Journal:  CMAJ Open       Date:  2016-08-22

6.  Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.

Authors:  Malini Madhavan; Jonathan W Waks; Paul A Friedman; Daniel B Kramer; Alfred E Buxton; Peter A Noseworthy; Ramila A Mehta; David O Hodge; Angela Y Higgins; Tracy L Webster; Chance M Witt; Yong-Mei Cha; Bernard J Gersh
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-03

7.  Impact of advanced age on survival in patients with implantable cardioverter defibrillators.

Authors:  Cara N Pellegrini; Keane Lee; Jeffrey E Olgin; Mintu P Turakhia; Zian H Tseng; Randall Lee; Nitish Badhwar; Byron Lee; Paul D Varosy
Journal:  Europace       Date:  2008-09-24       Impact factor: 5.214

Review 8.  Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis.

Authors:  Dominic A M J Theuns; Tim Smith; Myriam G M Hunink; Gust H Bardy; Luc Jordaens
Journal:  Europace       Date:  2010-11       Impact factor: 5.214

9.  Transient local injury current in right ventricular electrogram after implantable cardioverter-defibrillator shock predicts heart failure progression.

Authors:  Larisa G Tereshchenko; Mitchell N Faddis; Barry J Fetics; Karl E Zelik; Igor R Efimov; Ronald D Berger
Journal:  J Am Coll Cardiol       Date:  2009-08-25       Impact factor: 24.094

10.  Predictors of early mortality in implantable cardioverter-defibrillator recipients.

Authors:  Kenneth M Stein; Suneet Mittal; F Roosevelt Gilliam; David M Gilligan; Qian Zhong; Stacia Merkel Kraus; Timothy E Meyer
Journal:  Europace       Date:  2009-03-11       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.